Zymeworks Inc. (ZYME)
NASDAQ: ZYME · IEX Real-Time Price · USD
8.40
-0.21 (-2.44%)
Jul 2, 2024, 4:30 PM EDT - Market closed

Zymeworks Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2014
Net Income
-118.67124.34-211.84-180.55-145.44
Upgrade
Depreciation & Amortization
17.31129.5810.287.33
Upgrade
Share-Based Compensation
8.14.0210.7629.1249
Upgrade
Other Operating Activities
-25.043.75-0.95-10.257.26
Upgrade
Operating Cash Flow
-118.3144.11-192.45-151.4-81.85
Upgrade
Capital Expenditures
-2.47-8.15-12.4-4.31-6.32
Upgrade
Change in Investments
-203.18-40.72157.88-37.18-11.71
Upgrade
Other Investing Activities
-1.6-4.98-0.88-1.96-7.56
Upgrade
Investing Cash Flow
-207.25-53.85144.6-43.44-25.59
Upgrade
Share Issuance / Repurchase
81.92109.198.5309.13194.33
Upgrade
Debt Issued / Paid
-0.02-0.01-0.02-0.04-0.02
Upgrade
Other Financing Activities
-0.05-0.6-0.47-0.11-0.65
Upgrade
Financing Cash Flow
81.85108.588.01308.98193.66
Upgrade
Exchange Rate Effect
0.350.2-0.33-0.550.03
Upgrade
Net Cash Flow
-243.36199.05-40.17113.5986.25
Upgrade
Free Cash Flow
-120.78135.96-204.86-155.71-88.18
Upgrade
Free Cash Flow Margin
-158.89%32.96%-767.82%-399.77%-298.45%
Upgrade
Free Cash Flow Per Share
-1.752.08-3.97-3.09-2.32
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).